Vir Biotechnology (VIR) Non-cash Items (2019 - 2022)

Vir Biotechnology's Non-cash Items history runs 4 years deep, the most recent figure standing at $52.3 million for Q4 2022.

• In Q4 2022, Non-cash Items fell 70.35% year-over-year to $52.3 million; the TTM figure through Dec 2022 stood at $52.3 million (down 70.35% YoY), while the FY2022 annual figure was $52.3 million, down 70.35% from the prior year.
• Non-cash Items came in at $52.3 million for Q4 2022 at Vir Biotechnology, down from $65.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $250.2 million in Q2 2020 to a low of $52.3 million in Q4 2022.
• A 4-year average of $151.6 million and a median of $175.3 million in 2020 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items soared 98.44% in 2020 and slumped 70.35% in 2022, its largest moves.
• Vir Biotechnology's Non-cash Items stood at $55.1 million in 2019, then surged by 98.44% to $109.3 million in 2020, then surged by 61.43% to $176.4 million in 2021, then plunged by 70.35% to $52.3 million in 2022.
• According to Business Quant data, Non-cash Items over the past three periods registered $52.3 million, $65.5 million, and $176.4 million for Q4 2022, Q1 2022, and Q4 2021 respectively.

Peer Comparison